Monoclonal Antibody Therapy Against Chronic Herpes Simplex Virus 2 Infection

Clinical trial NCT04165122 · COMPLETED

Trial details

NCT number: NCT04165122
Sponsor: Heidelberg ImmunoTherapeutics GmbH
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Herpes Genitalis

Start date: 2019-11-15
Primary completion: 2021-08-25
Enrollment: 122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.